[6-K] DR REDDYS LABORATORIES LTD Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Dr. Reddy’s Laboratories Limited has scheduled a Board of Directors meeting for May 12, 2026 to consider the audited standalone and consolidated financial results for the quarter and financial year ending March 31, 2026.

The company also announced that, under SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in its securities will be closed from March 25, 2026 to May 14, 2026, both days inclusive.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

March, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x                             Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨                               No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation regarding Board Meeting

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: March 23, 2026	By:	/s/ K Randhir Singh
		Name: K Randhir Singh
		Title:  Company Secretary

3

Exhibit 99.1

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel:       + 91 40 4900 2900 Fax:     + 91 40 4900 2999 Email: mail@drreddys.com Web:   www.drreddys.com

March 23, 2026

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Intimation regarding Board meeting and Trading window closure

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, May 12, 2026, inter alia, to consider the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ending on March 31, 2026.

Further, kindly note that, under the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will be closed from March 25, 2026, to May 14, 2026 (both days inclusive).

This is for your information and records.

Thanking you,

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

FAQ

What did Dr. Reddy’s Laboratories (RDY) announce in this Form 6-K?

Dr. Reddy’s announced a Board meeting on May 12, 2026 to consider audited standalone and consolidated financial results for the quarter and financial year ending March 31, 2026, and disclosed the related trading window closure period.

When will Dr. Reddy’s Laboratories (RDY) Board meet to review FY 2026 results?

The Board of Directors will meet on Tuesday, May 12, 2026. At this meeting, they plan to consider the audited standalone and consolidated financial results for the quarter and full financial year ending March 31, 2026.

Which financial period’s results will Dr. Reddy’s (RDY) Board consider?

The Board will consider audited standalone and consolidated financial results for the quarter and the financial year ending on March 31, 2026. This covers both the final quarter and the full fiscal year performance of the company.

What is the trading window closure period for Dr. Reddy’s (RDY)?

The trading window for dealing in Dr. Reddy’s securities will be closed from March 25, 2026 to May 14, 2026, both days inclusive, under SEBI (Prohibition of Insider Trading) Regulations, 2015, surrounding the upcoming financial results consideration.

Why is Dr. Reddy’s (RDY) closing its trading window in March–May 2026?

The trading window is being closed under SEBI (Prohibition of Insider Trading) Regulations, 2015, because the Board will consider audited financial results. The closure runs from March 25, 2026 to May 14, 2026 to restrict trading during this sensitive period.

Which stock exchanges were notified about Dr. Reddy’s May 12, 2026 Board meeting?

Notifications were sent to the National Stock Exchange of India, BSE Limited, New York Stock Exchange Inc., and NSE IFSC Ltd., using their respective codes: DRREDDY, 500124, RDY, and DRREDDY.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 20.6 KB